1-2 of 2
Timothy J. Murphy, MD, FACP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia

Steven Peter Treon, MD, MA, PhD, Christina K Tripsas, MA, Kirsten Meid, MPH, Christopher Patterson, Leonard T Heffner, MD, Herbert Eradat, MS, MD, Stephanie A. Gregory, MD, Sheeba K. Thomas, M.D., Ranjana H. Advani, MD, Rachid Baz, Ashraf Z. Badros, MD, Jeffrey Matous, MD, Timothy J. Murphy, MD, FACP, Irene M. Ghobrial, MD
Journal: Blood
Blood (2013) 122 (21): 1822.
https://doi.org/10.1182/blood.V122.21.1822.1822
Published: 2013
Journal Articles

Final Results of the Phase II Trial of Single Agent Panobinostat (LBH589) in Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, MD, Ranjit Banwait, MA, Tiffany Poon, BS, Federico Campigotto, MS, Erica N Boswell, BS, Stacey Chuma, BSN, Janet Kunsman, NP, Amanda Donovan, BS, Meghan Bagshaw, Diane Warren, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Edie Weller, PhD, Timothy J. Murphy, MD, FACP, Jeffrey Matous, MD
Journal: Blood
Blood (2011) 118 (21): 2706.
https://doi.org/10.1182/blood.V118.21.2706.2706
Published: 2011